TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says. July 28, 2006